Certara to Participate in Upcoming Investor Conferences
November 02, 2022 17:00 ET
|
Certara
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
October 19, 2022 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Certara, Inc., (Nasdaq: CERT) a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)...
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
October 13, 2022 07:45 ET
|
Certara
PRINCETON, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Certara to Participate in Upcoming Investor Conferences
August 31, 2022 08:00 ET
|
Certara
PRINCETON, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Certara Announces Secondary Offering
August 11, 2022 16:38 ET
|
Certara
PRINCETON, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) (“Certara”), a global leader in biosimulation, today announced the sale by certain stockholders (the “Selling...
Certara Reports Second Quarter 2022 Financial Results
August 09, 2022 16:15 ET
|
Certara
PRINCETON, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the second quarter of fiscal year 2022 and...
Certara推出Pinnacle 21™ Enterprise更新和全新的Pinnacle 21™ Data Exchange 模块
August 09, 2022 00:48 ET
|
Certara USA, Inc.
新泽西州普林斯顿, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Certara, Inc.(纳斯达克股票代码：CERT)为全球生物模拟领域的领军企业，今日宣布发布Pinnacle 21 Enterprise 5.2.0版，这款软件是公司的旗舰软件，用于验证进行生物模拟和向监管机构递交材料所需的临床试验数据。Certara还推出了全新的Pinnacle 21 Data...
Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module
August 05, 2022 08:00 ET
|
Certara
PRINCETON, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release 5.2.0 of Pinnacle 21 Enterprise, the Company’s...
Certara宣布与行业领先的癌症中心合作推进CAR-T细胞疗法
July 29, 2022 06:22 ET
|
Certara USA, Inc.
新泽西州普林斯顿, July 29, 2022 (GLOBE NEWSWIRE) -- Certara, Inc.(纳斯达克股票代码：CERT)为全球生物模拟领域的领军企业，今日宣布与纪念斯隆-凯特琳癌症中心(Memorial Sloan-Kettering Cancer...
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
July 28, 2022 08:00 ET
|
Certara
PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a 2-year collaboration with Memorial Sloan Kettering Cancer Center...